Follow
Amal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
Other namesAmal Kamal Saadeldin
Associate Professor of Pharmacology & Toxicology, ASU and Postdoctoral Pharmacologist, IEO, Italy
Verified email at pharma.asu.edu.eg
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13048*2021
Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents
MA Aziz, RAT Serya, DS Lasheen, AK Abdel-Aziz, A Esmat, AM Mansour, ...
Scientific reports 6 (1), 24460, 2016
1392016
Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries
SE El-Agamy, AK Abdel-Aziz, S Wahdan, A Esmat, SS Azab
Molecular neurobiology 55, 5727-5740, 2018
1362018
Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries
AK Abdel-Aziz, S Shouman, E El-Demerdash, M Elgendy, AB Abdel-Naim
Chemico-biological interactions 217, 28-40, 2014
962014
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
SE El-Agamy, AK Abdel-Aziz, A Esmat, SS Azab
Cancer chemotherapy and pharmacology 84, 1-14, 2019
742019
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner
M Elgendy, M Ciro, AK Abdel-Aziz, G Belmonte, RD Zuffo, C Mercurio, ...
Nature communications 5 (1), 5637, 2014
722014
Dual modulation of MCL-1 and mTOR determines the response to sunitinib
M Elgendy, AK Abdel-Aziz, SL Renne, V Bornaghi, G Procopio, ...
The Journal of clinical investigation 127 (1), 153-168, 2017
502017
Surmounting the resistance against EGFR inhibitors through the development of thieno [2, 3-d] pyrimidine-based dual EGFR/HER2 inhibitors
SN Milik, AK Abdel-Aziz, DS Lasheen, RAT Serya, S Minucci, ...
European Journal of Medicinal Chemistry 155, 316-336, 2018
492018
The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries
AK Abdel-Aziz, EM Mantawy, RS Said, R Helwa
Experimental neurology 283, 129-141, 2016
472016
Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis
MK Saadeldin, AK Abdel-Aziz, A Abdellatif
Medical hypotheses 146, 110365, 2021
442021
Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: emphasis on TGF-β/MAPKs …
EM Mantawy, RS Said, AK Abdel-Aziz
Biomedicine & Pharmacotherapy 109, 293-303, 2019
442019
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
MK Saadeldin, SS Elshaer, IA Emara, M Maged, AK Abdel-Aziz
PLoS One 13 (11), e0206761, 2018
372018
Rational design, synthesis and molecular modeling studies of novel anti-oncological alkaloids against melanoma
AS Girgis, SS Panda, AM Srour, H Farag, NSM Ismail, M Elgendy, ...
Organic & Biomolecular Chemistry 13 (23), 6619-6633, 2015
352015
Modulation of imatinib cytotoxicity by selenite in HCT 116 colorectal cancer cells
AK Abdel‐Aziz, SSE Azab, SS Youssef, AM El‐Sayed, E El‐Demerdash, ...
Basic & clinical pharmacology & toxicology 116 (1), 37-46, 2015
292015
Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition
AK Abdel-Aziz, I Pallavicini, E Ceccacci, G Meroni, MK Saadeldin, ...
haematologica 105 (8), 2105, 2020
28*2020
Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis
AES Abdel-Maged, AM Gad, AK Abdel-Aziz, MM Aboulwafa, SS Azab
Toxicology and Applied Pharmacology 356, 65-75, 2018
262018
From resistance to sensitivity: insights and implications of biphasic modulation of autophagy by sunitinib
AK Abdel-Aziz, AB Abdel-Naim, S Minucci
Frontiers in Pharmacology 8, 288684, 2017
262017
Chloroquine as a promising adjuvant chemotherapy together with sunitinib
AK Abdel-Aziz, S Shouman, E El-Demerdash, M Elgendy, AB Abdel-Naim
strategies 12, 15, 2014
152014
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia
EME Dokla, AK Abdel-Aziz, SN Milik, MJ McPhillie, S Minucci, ...
Bioorganic & Medicinal Chemistry 56, 116596, 2022
102022
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside
AK Abdel-Aziz, MK Saadeldin, P D'Amico, S Orecchioni, F Bertolini, ...
European Journal of Cancer 122, 22-41, 2019
92019
The system can't perform the operation now. Try again later.
Articles 1–20